Zhejiang Huahai Pharmaceutical Co., Ltd. (SHA:600521)

China · Delayed Price · Currency is CNY

14.41

-0.33 (-2.24%)

Jun 10, 2026, 3:00 PM CST

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Sales of Raw Materials and Intermediates	3.47B	3.65B	-	-	-
Sales of Raw Materials and Intermediates Growth	-4.86%	-	-	-	-
Sales of Drug Product	5.00B	5.76B	-	-	-
Sales of Drug Product Growth	-13.15%	-	-	-	-
Technical Services	44.90M	62.88M	-	-	-
Technical Services Growth	-28.60%	-	-	-	-
Others	69.75M	77.69M	-	-	-
Others Growth	-10.22%	-	-	-	-
Total	8.59B	9.55B	-	-	-
Total Growth	-10.06%	-	-	-	-

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
China	4.30B	5.03B	-	-	-
China Growth	-14.47%	-	-	-	-
Foreign	4.28B	4.51B	-	-	-
Foreign Growth	-5.15%	-	-	-	-
Total	8.59B	9.55B	-	-	-
Total Growth	-10.06%	-	-	-	-

Source: S&P Global Market Intelligence.